Michael Keller

Roche (Switzerland)

Papers

1

Total Citations

32

H-Index

1

About

Michael Keller is a leading researcher in the field of drug delivery and nanomedicine, with a particular focus on lipid nanoparticle (LNP) formulations. His work is pivotal in understanding how the structural properties of LNPs influence their performance in therapeutic applications, including mRNA vaccines and gene therapies. Keller's most-cited paper, "Impact of non-ionizable lipids and phase mixing methods on structural properties of lipid nanoparticle formulations" (2023, 32 citations), provides critical insights into how lipid composition and manufacturing processes affect nanoparticle stability and efficacy. This research has significant implications for optimizing LNP design, directly impacting the development of next-generation vaccines and targeted drug delivery systems. By elucidating the role of non-ionizable lipids and phase mixing, Keller has helped bridge the gap between fundamental materials science and practical pharmaceutical engineering. His contributions are essential for researchers and students aiming to refine LNP technologies for more effective and safer therapeutic outcomes.

Research Focus

Key Achievements

1
H-Index
1
Papers
32
Total Citations
32
Avg Citations/Paper
🏆 Most Cited Paper
Impact of non-ionizable lipids and phase mixing methods on structural properties of lipid nanoparticle formulations
32 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Roche (Switzerland)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago